Dr. Quynh-Thu Xuan Le, MD

Dr. Le practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Le's NPI, 1316002116, was assigned on December 22, 2006. Dr. Le graduated from UCSF School of Medicine in 1993. Dr. Le holds California license G079675.

Dr. Le's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Le's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Le to 1 more hospital, named with a free account. Dr. Le's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Le practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Le's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Le is board certified in radiation oncology by the American Board of Radiology. Dr. Le is licensed in California.

Dmand AI lists head & neck cancer radiation among the conditions Dr. Le treats.

CMS data shows 417 Medicare services from Dr. Le across 8 procedure codes in 2024, for 96 Medicare patients. Medicare paid $27,468 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Dr. Le in 2024. The largest group is 65 to 74, with 45 patients. 68% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Le's median patient age at 64, with 26% women.

In 2024, Dr. Le wrote 39 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $464 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Le for performance year 2024, reported as part of a group. Dr. Le accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Le as offering telehealth.

Dmand AI links 347 papers to Dr. Le, published from 2004 to 2025. 2016 was the busiest year, with 22. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Lung Neoplasms. Dr. Le has published most often in Int J Radiat Oncol Biol Phys. Dr. Le's most frequent co-authors are Billy W. Loo, MD, PhD, Albert C. Koong, MD, PhD and Christina Suzan Kong, MD.

Dmand AI links Dr. Le to 23 clinical trials, 5 of them phase 1 studies. 9 are still active or recruiting. Conditions studied include Head and Neck Neoplasms, Carcinoma, Squamous Cell and Lip Neoplasms. Stanford University sponsors the most, 14.

CMS Open Payments shows 37 general payments to Dr. Le from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Merck Sharp & Dohme Corporation paid the most, $10,014.

Dmand AI lists 3 awards for Dr. Le, most recently America's Top Doctors in 2014.

Dr. Le graduated from UCSF School of Medicine in 1993.

Dr. Le is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.